We next isolated CD4-1+ T cells from the tumors (tumor-infiltrating lymphocytes [TILs]) and compared gene expression to wild-type CD4-1+ T cells isolated from the kidney and spleen. The gene discussed is ITGA2B; the disease is neoplasm.